May 7, 2024
James Helzberg
Share
Article Link: https://pubmed.ncbi.nlm.nih.gov/36626622/
What regimens are most effective for induction and maintenance therapy for patients with autoimmune hepatitis?
April 1, 2022
Can Efruxifermin Reverse Fibrosis in Compensated MASH Cirrhosis?
April 28, 2026
Pediatric Autoimmune Hepatitis: Is Treatment Withdrawal Possible and Safe?
March 16, 2026
